{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T12:23:38Z","timestamp":1759667018579},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2010,6,25]],"date-time":"2010-06-25T00:00:00Z","timestamp":1277424000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Familial Cancer"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1007\/s10689-010-9362-5","type":"journal-article","created":{"date-parts":[[2010,6,24]],"date-time":"2010-06-24T09:44:59Z","timestamp":1277372699000},"page":"545-553","source":"Crossref","is-referenced-by-count":18,"title":["The contribution of breast cancer pathology to statistical models to predict mutation risk in BRCA carriers"],"prefix":"10.1007","volume":"9","author":[{"given":"Ana Cristina","family":"Vargas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonard Da","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunil R.","family":"Lakhani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,6,25]]},"reference":[{"issue":"18","key":"9362_CR1","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1093\/jnci\/94.18.1358","volume":"94","author":"D Thompson","year":"2002","unstructured":"Thompson D, Easton DF (2002) Cancer incidence in BRCA1 mutation carriers. J Natl Cancer Inst 94(18):1358\u20131365","journal-title":"J Natl Cancer Inst"},{"issue":"23","key":"9362_CR2","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1056\/NEJMra012284","volume":"348","author":"R Wooster","year":"2003","unstructured":"Wooster R, Weber BL (2003) Breast and ovarian cancer. N Engl J Med 348(23):2339\u20132347","journal-title":"N Engl J Med"},{"issue":"2","key":"9362_CR3","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0092-8674(02)00615-3","volume":"108","author":"AR Venkitaraman","year":"2002","unstructured":"Venkitaraman AR (2002) Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell 108(2):171\u2013182","journal-title":"Cell"},{"issue":"5","key":"9362_CR4","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1365-2559.2006.02538.x","volume":"49","author":"RL Balleine","year":"2006","unstructured":"Balleine RL, Murali R, Bilous AM et al (2006) Histopathological features of breast cancer in carriers of ATM gene variants. Histopathology 49(5):523\u2013532","journal-title":"Histopathology"},{"issue":"1","key":"9362_CR5","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1399-0004.2008.01111.x","volume":"75","author":"C Cybulski","year":"2009","unstructured":"Cybulski C, Huzarski T, Byrski T et al (2009) Estrogen receptor status in CHEK2-positive breast cancers: implications for chemoprevention. Clin Genet 75(1):72\u201378","journal-title":"Clin Genet"},{"issue":"4","key":"9362_CR6","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1200\/JCO.2003.07.007","volume":"21","author":"SM Domchek","year":"2003","unstructured":"Domchek SM, Eisen A, Calzone K, Stopfer J, Blackwood A, Weber BL (2003) Application of breast cancer risk prediction models in clinical practice. J Clin Oncol 21(4):593\u2013601","journal-title":"J Clin Oncol"},{"issue":"23","key":"9362_CR7","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1001\/jama.297.23.2587","volume":"297","author":"JN Weitzel","year":"2007","unstructured":"Weitzel JN, Lagos VI, Cullinane CA et al (2007) Limited family structure and BRCA gene mutation status in single cases of breast cancer. JAMA 297(23):2587\u20132595","journal-title":"JAMA"},{"issue":"8","key":"9362_CR8","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1200\/JCO.2008.17.5869","volume":"27","author":"D Huo","year":"2009","unstructured":"Huo D, Senie RT, Daly M et al (2009) Prediction of BRCA mutations using the BRCAPRO model in clinic-based African American, hispanic, and other minority families in the United States. J Clin Oncol 27(8):1184\u20131190","journal-title":"J Clin Oncol"},{"issue":"11","key":"9362_CR9","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1136\/jmg.2008.061903","volume":"45","author":"PA James","year":"2008","unstructured":"James PA, Harris M, Lindeman GJ, Mitchell G (2008) Towards more effective and equitable genetic testing for BRCA1 and BRCA2 mutation carriers. J Med Genet 45(11):765\u2013766","journal-title":"J Med Genet"},{"issue":"7","key":"9362_CR10","doi-asserted-by":"crossref","first-page":"441","DOI":"10.7326\/0003-4819-147-7-200710020-00002","volume":"147","author":"G Parmigiani","year":"2007","unstructured":"Parmigiani G, Chen S, Iversen ES Jr et al (2007) Validity of models for predicting BRCA1 and BRCA2 mutations. Ann Intern Med 147(7):441\u2013450","journal-title":"Ann Intern Med"},{"issue":"4","key":"9362_CR11","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1158\/1055-9965.EPI-08-1090","volume":"18","author":"AW Kurian","year":"2009","unstructured":"Kurian AW, Gong GD, John EM et al (2009) Performance of prediction models for BRCA mutation carriage in three racial\/ethnic groups: findings from the Northern California breast cancer family registry. Cancer Epidemiol Biomarkers Prev 18(4):1084\u20131091","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"9362_CR12","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/cncr.10223","volume":"94","author":"KM Shannon","year":"2002","unstructured":"Shannon KM, Lubratovich ML, Finkelstein DM, Smith BL, Powell SN, Seiden MV (2002) Model-based predictions of BRCA1\/2 mutation status in breast carcinoma patients treated at an academic medical center. Cancer 94(2):305\u2013313","journal-title":"Cancer"},{"issue":"6","key":"9362_CR13","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1200\/JCO.2002.20.6.1480","volume":"20","author":"TS Frank","year":"2002","unstructured":"Frank TS, Deffenbaugh AM, Reid JE et al (2002) Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals. J Clin Oncol 20(6):1480\u20131490","journal-title":"J Clin Oncol"},{"issue":"5","key":"9362_CR14","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/375033","volume":"72","author":"A Antoniou","year":"2003","unstructured":"Antoniou A, Pharoah PD, Narod S et al (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72(5):1117\u20131130","journal-title":"Am J Hum Genet"},{"key":"9362_CR15","unstructured":"Struewing JP, Watson P, Easton DF, Ponder BA, Lynch HT, Tucker MA (1995) Prophylactic oophorectomy in inherited breast\/ovarian cancer families. J Natl Cancer Inst Monogr (17): 33\u201335"},{"issue":"17","key":"9362_CR16","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1093\/jnci\/91.17.1475","volume":"91","author":"TR Rebbeck","year":"1999","unstructured":"Rebbeck TR, Levin AM, Eisen A et al (1999) Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers. J Natl Cancer Inst 91(17):1475\u20131479","journal-title":"J Natl Cancer Inst"},{"issue":"21","key":"9362_CR17","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1093\/jnci\/93.21.1633","volume":"93","author":"LC Hartmann","year":"2001","unstructured":"Hartmann LC, Sellers TA, Schaid DJ et al (2001) Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. J Natl Cancer Inst 93(21):1633\u20131637","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"9362_CR18","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1056\/NEJM200107193450301","volume":"345","author":"H Meijers-Heijboer","year":"2001","unstructured":"Meijers-Heijboer H, van Geel B, van Putten WL et al (2001) Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med 345(3):159\u2013164","journal-title":"N Engl J Med"},{"issue":"21","key":"9362_CR19","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa020119","volume":"346","author":"ND Kauff","year":"2002","unstructured":"Kauff ND, Satagopan JM, Robson ME et al (2002) Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med 346(21):1609\u20131615","journal-title":"N Engl J Med"},{"issue":"6","key":"9362_CR20","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1200\/JCO.2004.04.188","volume":"22","author":"TR Rebbeck","year":"2004","unstructured":"Rebbeck TR, Friebel T, Lynch HT et al (2004) Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE study group. J Clin Oncol 22(6):1055\u20131062","journal-title":"J Clin Oncol"},{"issue":"20","key":"9362_CR21","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1056\/NEJM199705153362002","volume":"336","author":"FJ Couch","year":"1997","unstructured":"Couch FJ, DeShano ML, Blackwood MA et al (1997) BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. N Engl J Med 336(20):1409\u20131415","journal-title":"N Engl J Med"},{"issue":"1","key":"9362_CR22","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1086\/301670","volume":"62","author":"G Parmigiani","year":"1998","unstructured":"Parmigiani G, Berry D, Aguilar O (1998) Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2. Am J Hum Genet 62(1):145\u2013158","journal-title":"Am J Hum Genet"},{"issue":"11","key":"9362_CR23","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1200\/JCO.2002.05.121","volume":"20","author":"DA Berry","year":"2002","unstructured":"Berry DA, Iversen ES Jr, Gudbjartsson DF et al (2002) BRCAPRO validation, sensitivity of genetic testing of BRCA1\/BRCA2, and prevalence of other breast cancer susceptibility genes. J Clin Oncol 20(11):2701\u20132712","journal-title":"J Clin Oncol"},{"issue":"6","key":"9362_CR24","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1136\/jmg.2003.017996","volume":"41","author":"DG Evans","year":"2004","unstructured":"Evans DG, Eccles DM, Rahman N et al (2004) A new scoring system for the chances of identifying a BRCA1\/2 mutation outperforms existing models including BRCAPRO. J Med Genet 41(6):474\u2013480","journal-title":"J Med Genet"},{"issue":"8","key":"9362_CR25","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1038\/sj.bjc.6604305","volume":"98","author":"AC Antoniou","year":"2008","unstructured":"Antoniou AC, Cunningham AP, Peto J et al (2008) The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions. Br J Cancer 98(8):1457\u20131466","journal-title":"Br J Cancer"},{"issue":"7","key":"9362_CR26","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/sim.1668","volume":"23","author":"J Tyrer","year":"2004","unstructured":"Tyrer J, Duffy SW, Cuzick J (2004) A breast cancer prediction model incorporating familial and personal risk factors. Stat Med 23(7):1111\u20131130","journal-title":"Stat Med"},{"issue":"3","key":"9362_CR27","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/jnci\/89.3.227","volume":"89","author":"DA Berry","year":"1997","unstructured":"Berry DA, Parmigiani G, Sanchez J, Schildkraut J, Winer E (1997) Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history. J Natl Cancer Inst 89(3):227\u2013238","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"9362_CR28","first-page":"228","volume":"5","author":"KA Calzone","year":"1997","unstructured":"Calzone KA, Stopfer J, Blackwood A, Weber BL (1997) Establishing a cancer risk evaluation program. Cancer Pract 5(4):228\u2013233","journal-title":"Cancer Pract"},{"issue":"7","key":"9362_CR29","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1200\/JCO.1998.16.7.2417","volume":"16","author":"TS Frank","year":"1998","unstructured":"Frank TS, Manley SA, Olopade OI et al (1998) Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk. J Clin Oncol 16(7):2417\u20132425","journal-title":"J Clin Oncol"},{"issue":"12","key":"9362_CR30","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1093\/aje\/152.12.1154","volume":"152","author":"H Anderson","year":"2000","unstructured":"Anderson H, Bladstrom A, Olsson H, Moller TR (2000) Familial breast and ovarian cancer: a Swedish population-based register study. Am J Epidemiol 152(12):1154\u20131163","journal-title":"Am J Epidemiol"},{"issue":"8","key":"9362_CR31","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1038\/sj.bjc.6602175","volume":"91","author":"AC Antoniou","year":"2004","unstructured":"Antoniou AC, Pharoah PP, Smith P, Easton DF (2004) The BOADICEA model of genetic susceptibility to breast and ovarian cancer. Br J Cancer 91(8):1580\u20131590","journal-title":"Br J Cancer"},{"issue":"7","key":"9362_CR32","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1136\/jmg.2005.031989","volume":"42","author":"DG Evans","year":"2005","unstructured":"Evans DG, Lalloo F, Wallace A, Rahman N (2005) Update on the manchester scoring system for BRCA1 and BRCA2 testing. J Med Genet 42(7):e39","journal-title":"J Med Genet"},{"issue":"12","key":"9362_CR33","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1136\/jmg.2009.067850","volume":"46","author":"DG Evans","year":"2009","unstructured":"Evans DG, Lalloo F, Cramer A et al (2009) Addition of pathology and biomarker information significantly improves the performance of the manchester scoring system for BRCA1 and BRCA2 testing. J Med Genet 46(12):811\u2013817","journal-title":"J Med Genet"},{"issue":"7","key":"9362_CR34","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1136\/jmg.2007.056556","volume":"45","author":"AC Antoniou","year":"2008","unstructured":"Antoniou AC, Hardy R, Walker L et al (2008) Predicting the likelihood of carrying a BRCA1 or BRCA2 mutation: validation of BOADICEA, BRCAPRO, IBIS, myriad and the manchester scoring system using data from UK genetics clinics. J Med Genet 45(7):425\u2013431","journal-title":"J Med Genet"},{"issue":"3","key":"9362_CR35","first-page":"782","volume":"6","author":"SR Lakhani","year":"2000","unstructured":"Lakhani SR, Gusterson BA, Jacquemier J et al (2000) The pathology of familial breast cancer: histological features of cancers in families not attributable to mutations in BRCA1 or BRCA2. Clin Cancer Res 6(3):782\u2013789","journal-title":"Clin Cancer Res"},{"issue":"15","key":"9362_CR36","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1093\/jnci\/90.15.1138","volume":"90","author":"SR Lakhani","year":"1998","unstructured":"Lakhani SR, Jacquemier J, Sloane JP et al (1998) Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations. J Natl Cancer Inst 90(15):1138\u20131145","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"9362_CR37","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1158\/1078-0432.CCR-05-2230","volume":"12","author":"RA Oldenburg","year":"2006","unstructured":"Oldenburg RA, Kroeze-Jansema K, Meijers-Heijboer H et al (2006) Characterization of familial non-BRCA1\/2 breast tumors by loss of heterozygosity and immunophenotyping. Clin Cancer Res 12(6):1693\u20131700","journal-title":"Clin Cancer Res"},{"issue":"1","key":"9362_CR38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/B:BREA.0000003836.91844.b5","volume":"82","author":"E Sensi","year":"2003","unstructured":"Sensi E, Tancredi M, Aretini P et al (2003) p53 inactivation is a rare event in familial breast tumors negative for BRCA1 and BRCA2 mutations. Breast Cancer Res Treat 82(1):1\u20139","journal-title":"Breast Cancer Res Treat"},{"issue":"9","key":"9362_CR39","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1200\/JCO.2002.09.023","volume":"20","author":"SR Lakhani","year":"2002","unstructured":"Lakhani SR, Van De Vijver MJ, Jacquemier J et al (2002) The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2. J Clin Oncol 20(9):2310\u20132318","journal-title":"J Clin Oncol"},{"issue":"10 Pt 1","key":"9362_CR40","first-page":"3606","volume":"9","author":"J Palacios","year":"2003","unstructured":"Palacios J, Honrado E, Osorio A et al (2003) Immunohistochemical characteristics defined by tissue microarray of hereditary breast cancer not attributable to BRCA1 or BRCA2 mutations: differences from breast carcinomas arising in BRCA1 and BRCA2 mutation carriers. Clin Cancer Res 9(10 Pt 1):3606\u20133614","journal-title":"Clin Cancer Res"},{"issue":"12","key":"9362_CR41","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1038\/modpathol.3800969","volume":"20","author":"E Honrado","year":"2007","unstructured":"Honrado E, Osorio A, Milne RL et al (2007) Immunohistochemical classification of non-BRCA1\/2 tumors identifies different groups that demonstrate the heterogeneity of BRCAX families. Mod Pathol 20(12):1298\u20131306","journal-title":"Mod Pathol"},{"issue":"14","key":"9362_CR42","doi-asserted-by":"crossref","first-page":"5175","DOI":"10.1158\/1078-0432.CCR-04-2424","volume":"11","author":"SR Lakhani","year":"2005","unstructured":"Lakhani SR, Reis-Filho JS, Fulford L et al (2005) Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype. Clin Cancer Res 11(14):5175\u20135180","journal-title":"Clin Cancer Res"},{"issue":"3","key":"9362_CR43","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1158\/0008-5472.CAN-03-2970","volume":"64","author":"WD Foulkes","year":"2004","unstructured":"Foulkes WD, Brunet JS, Stefansson IM et al (2004) The prognostic implication of the basal-like (cyclin E high\/p27 low\/p53+\/glomeruloid-microvascular-proliferation+) phenotype of BRCA1-related breast cancer. Cancer Res 64(3):830\u2013835","journal-title":"Cancer Res"},{"issue":"4","key":"9362_CR44","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1080\/00313020220147113","volume":"34","author":"JE Armes","year":"2002","unstructured":"Armes JE, Venter DJ (2002) The pathology of inherited breast cancer. Pathology 34(4):309\u2013314","journal-title":"Pathology"},{"issue":"1","key":"9362_CR45","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s10549-006-9184-1","volume":"99","author":"SM Pinilla","year":"2006","unstructured":"Pinilla SM, Honrado E, Hardisson D, Benitez J, Palacios J (2006) Caveolin-1 expression is associated with a basal-like phenotype in sporadic and hereditary breast cancer. Breast Cancer Res Treat 99(1):85\u201390","journal-title":"Breast Cancer Res Treat"},{"issue":"7","key":"9362_CR46","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1158\/1078-0432.CCR-08-2132","volume":"15","author":"EA Rakha","year":"2009","unstructured":"Rakha EA, Elsheikh SE, Aleskandarany MA et al (2009) Triple-negative breast cancer: distinguishing between basal and nonbasal subtypes. Clin Cancer Res 15(7):2302\u20132310","journal-title":"Clin Cancer Res"},{"issue":"10","key":"9362_CR47","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1038\/sj.bjc.6602557","volume":"92","author":"F Weber","year":"2005","unstructured":"Weber F, Fukino K, Sawada T et al (2005) Variability in organ-specific EGFR mutational spectra in tumour epithelium and stroma may be the biological basis for differential responses to tyrosine kinase inhibitors. Br J Cancer 92(10):1922\u20131926","journal-title":"Br J Cancer"},{"issue":"43","key":"9362_CR48","doi-asserted-by":"crossref","first-page":"5837","DOI":"10.1038\/sj.onc.1209875","volume":"25","author":"E Honrado","year":"2006","unstructured":"Honrado E, Osorio A, Palacios J, Benitez J (2006) Pathology and gene expression of hereditary breast tumors associated with BRCA1, BRCA2 and CHEK2 gene mutations. Oncogene 25(43):5837\u20135845","journal-title":"Oncogene"},{"issue":"5","key":"9362_CR49","first-page":"1206","volume":"60","author":"R Lidereau","year":"2000","unstructured":"Lidereau R, Eisinger F, Champeme MH et al (2000) Major improvement in the efficacy of BRCA1 mutation screening using morphoclinical features of breast cancer. Cancer Res 60(5):1206\u20131210","journal-title":"Cancer Res"},{"issue":"6","key":"9362_CR50","first-page":"1739","volume":"7","author":"J Chang","year":"2001","unstructured":"Chang J, Hilsenbeck SG, Sng JH, Wong J, Ragu GC (2001) Pathological features and BRCA1 mutation screening in premenopausal breast cancer patients. Clin Cancer Res 7(6):1739\u20131742","journal-title":"Clin Cancer Res"},{"issue":"2","key":"9362_CR51","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/(SICI)1098-2264(200002)27:2<130::AID-GCC3>3.0.CO;2-U","volume":"27","author":"L Cortesi","year":"2000","unstructured":"Cortesi L, Turchetti D, Bertoni C et al (2000) Comparison between genotype and phenotype identifies a high-risk population carrying BRCA1 mutations. Genes Chromosomes Cancer 27(2):130\u2013135","journal-title":"Genes Chromosomes Cancer"},{"issue":"11","key":"9362_CR52","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1097\/01.pas.0000213273.22844.1a","volume":"30","author":"G Farshid","year":"2006","unstructured":"Farshid G, Balleine RL, Cummings M, Waring P (2006) Morphology of breast cancer as a means of triage of patients for BRCA1 genetic testing. Am J Surg Pathol 30(11):1357\u20131366","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"9362_CR53","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/(SICI)1097-0215(19990621)84:3<263::AID-IJC11>3.0.CO;2-G","volume":"84","author":"F Eisinger","year":"1999","unstructured":"Eisinger F, Nogues C, Guinebretiere JM et al (1999) Novel indications for BRCA1 screening using individual clinical and morphological features. Int J Cancer 84(3):263\u2013267","journal-title":"Int J Cancer"},{"key":"9362_CR54","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1471-2407-9-86","volume":"9","author":"SR Young","year":"2009","unstructured":"Young SR, Pilarski RT, Donenberg T et al (2009) The prevalence of BRCA1 mutations among young women with triple-negative breast cancer. BMC Cancer 9:86","journal-title":"BMC Cancer"},{"issue":"11","key":"9362_CR55","doi-asserted-by":"crossref","first-page":"4003","DOI":"10.1158\/1078-0432.CCR-04-2064","volume":"11","author":"JB Arnes","year":"2005","unstructured":"Arnes JB, Brunet JS, Stefansson I et al (2005) Placental cadherin and the basal epithelial phenotype of BRCA1-related breast cancer. Clin Cancer Res 11(11):4003\u20134011","journal-title":"Clin Cancer Res"},{"issue":"7","key":"9362_CR56","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1097\/PAS.0b013e31819c1c93","volume":"33","author":"LC Collins","year":"2009","unstructured":"Collins LC, Martyniak A, Kandel MJ et al (2009) Basal cytokeratin and epidermal growth factor receptor expression are not predictive of BRCA1 mutation status in women with triple-negative breast cancers. Am J Surg Pathol 33(7):1093\u20131097","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"9362_CR57","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/jnci\/91.5.469","volume":"91","author":"KA Phillips","year":"1999","unstructured":"Phillips KA, Nichol K, Ozcelik H et al (1999) Frequency of p53 mutations in breast carcinomas from Ashkenazi Jewish carriers of BRCA1 mutations. J Natl Cancer Inst 91(5):469\u2013473","journal-title":"J Natl Cancer Inst"},{"issue":"13","key":"9362_CR58","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1038\/sj.onc.1202106","volume":"17","author":"T Crook","year":"1998","unstructured":"Crook T, Brooks LA, Crossland S et al (1998) p53 mutation with frequent novel condons but not a mutator phenotype in BRCA1- and BRCA2-associated breast tumours. Oncogene 17(13):1681\u20131689","journal-title":"Oncogene"},{"issue":"8","key":"9362_CR59","first-page":"2011","volume":"59","author":"JE Armes","year":"1999","unstructured":"Armes JE, Trute L, White D et al (1999) Distinct molecular pathogeneses of early-onset breast cancers in BRCA1 and BRCA2 mutation carriers: a population-based study. Cancer Res 59(8):2011\u20132017","journal-title":"Cancer Res"},{"issue":"3","key":"9362_CR60","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00019606-199609000-00007","volume":"5","author":"DW Visscher","year":"1996","unstructured":"Visscher DW, Sarkar FH, Shimoyama RK, Crissman JD (1996) Correlation between p53 immunostaining patterns and gene sequence mutations in breast carcinoma. Diagn Mol Pathol 5(3):187\u2013193","journal-title":"Diagn Mol Pathol"},{"issue":"8","key":"9362_CR61","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.1158\/0008-5472.CAN-08-3426","volume":"69","author":"H Holstege","year":"2009","unstructured":"Holstege H, Joosse SA, van Oostrom CT, Nederlof PM, de Vries A, Jonkers J (2009) High incidence of protein-truncating TP53 mutations in BRCA1-related breast cancer. Cancer Res 69(8):3625\u20133633","journal-title":"Cancer Res"},{"issue":"2","key":"9362_CR62","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1158\/0008-5472.CAN-08-1560","volume":"69","author":"E Manie","year":"2009","unstructured":"Manie E, Vincent-Salomon A, Lehmann-Che J et al (2009) High frequency of TP53 mutation in BRCA1 and sporadic basal-like carcinomas but not in BRCA1 luminal breast tumors. Cancer Res 69(2):663\u2013671","journal-title":"Cancer Res"},{"issue":"3","key":"9362_CR63","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/90108","volume":"28","author":"X Xu","year":"2001","unstructured":"Xu X, Qiao W, Linke SP et al (2001) Genetic interactions between tumor suppressors Brca1 and p53 in apoptosis, cell cycle and tumorigenesis. Nat Genet 28(3):266\u2013271","journal-title":"Nat Genet"},{"issue":"24","key":"9362_CR64","doi-asserted-by":"crossref","first-page":"3749","DOI":"10.1038\/sj.onc.1206439","volume":"22","author":"PP Ongusaha","year":"2003","unstructured":"Ongusaha PP, Ouchi T, Kim KT et al (2003) BRCA1 shifts p53-mediated cellular outcomes towards irreversible growth arrest. Oncogene 22(24):3749\u20133758","journal-title":"Oncogene"},{"issue":"6","key":"9362_CR65","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1158\/0008-5472.CAN-03-2270","volume":"64","author":"AM Cheung","year":"2004","unstructured":"Cheung AM, Elia A, Tsao MS et al (2004) Brca2 deficiency does not impair mammary epithelium development but promotes mammary adenocarcinoma formation in p53(+\/\u2212) mutant mice. Cancer Res 64(6):1959\u20131965","journal-title":"Cancer Res"},{"issue":"1","key":"9362_CR66","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s10549-004-1536-0","volume":"90","author":"J Palacios","year":"2005","unstructured":"Palacios J, Honrado E, Osorio A et al (2005) Phenotypic characterization of BRCA1 and BRCA2 tumors based in a tissue microarray study with 37 immunohistochemical markers. Breast Cancer Res Treat 90(1):5\u201314","journal-title":"Breast Cancer Res Treat"},{"issue":"6","key":"9362_CR67","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1136\/jcp.2005.032151","volume":"59","author":"P Groep van der","year":"2006","unstructured":"van der Groep P, Bouter A, van der Zanden R et al (2006) Distinction between hereditary and sporadic breast cancer on the basis of clinicopathological data. J Clin Pathol 59(6):611\u2013617","journal-title":"J Clin Pathol"},{"issue":"2","key":"9362_CR68","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.cancergencyto.2008.11.003","volume":"189","author":"D Gadzicki","year":"2009","unstructured":"Gadzicki D, Schubert A, Fischer C et al (2009) Histopathological criteria and selection algorithms for BRCA1 genetic testing. Cancer Genet Cytogenet 189(2):105\u2013111","journal-title":"Cancer Genet Cytogenet"},{"issue":"10","key":"9362_CR69","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1054\/bjoc.2000.1438","volume":"83","author":"P Freneaux","year":"2000","unstructured":"Freneaux P, Stoppa-Lyonnet D, Mouret E et al (2000) Low expression of bcl-2 in Brca1-associated breast cancers. Br J Cancer 83(10):1318\u20131322","journal-title":"Br J Cancer"},{"issue":"4","key":"9362_CR70","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1136\/mp.54.4.259","volume":"54","author":"SA Vaziri","year":"2001","unstructured":"Vaziri SA, Tubbs RR, Darlington G, Casey G (2001) Absence of CCND1 gene amplification in breast tumours of BRCA1 mutation carriers. Mol Pathol 54(4):259\u2013263","journal-title":"Mol Pathol"},{"issue":"6","key":"9362_CR71","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.humpath.2007.10.011","volume":"39","author":"EA Rakha","year":"2008","unstructured":"Rakha EA, El-Sheikh SE, Kandil MA, El-Sayed ME, Green AR, Ellis IO (2008) Expression of BRCA1 protein in breast cancer and its prognostic significance. Hum Pathol 39(6):857\u2013865","journal-title":"Hum Pathol"},{"issue":"1","key":"9362_CR72","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1073\/pnas.98.1.130","volume":"98","author":"C Beger","year":"2001","unstructured":"Beger C, Pierce LN, Kruger M et al (2001) Identification of Id4 as a regulator of BRCA1 expression by using a ribozyme-library-based inverse genomics approach. Proc Natl Acad Sci U S A 98(1):130\u2013135","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"14","key":"9362_CR73","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1038\/sj.onc.1210014","volume":"26","author":"NC Turner","year":"2007","unstructured":"Turner NC, Reis-Filho JS, Russell AM et al (2007) BRCA1 dysfunction in sporadic basal-like breast cancer. Oncogene 26(14):2126\u20132132","journal-title":"Oncogene"},{"issue":"2","key":"9362_CR74","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1158\/1940-6207.CAPR-08-0050","volume":"2","author":"B Arun","year":"2009","unstructured":"Arun B, Vogel KJ, Lopez A et al (2009) High prevalence of preinvasive lesions adjacent to BRCA1\/2-associated breast cancers. Cancer Prev Res (Phila Pa) 2(2):122\u2013127","journal-title":"Cancer Prev Res (Phila Pa)"},{"issue":"1","key":"9362_CR75","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/01.pas.0000213351.49767.0f","volume":"31","author":"AL Bane","year":"2007","unstructured":"Bane AL, Beck JC, Bleiweiss I et al (2007) BRCA2 mutation-associated breast cancers exhibit a distinguishing phenotype based on morphology and molecular profiles from tissue microarrays. Am J Surg Pathol 31(1):121\u2013128","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"9362_CR76","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/path.2358","volume":"215","author":"PT Simpson","year":"2008","unstructured":"Simpson PT, Reis-Filho JS, Lambros MB et al (2008) Molecular profiling pleomorphic lobular carcinomas of the breast: evidence for a common molecular genetic pathway with classic lobular carcinomas. J Pathol 215(3):231\u2013244","journal-title":"J Pathol"},{"issue":"4","key":"9362_CR77","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1200\/JCO.2005.01.9737","volume":"24","author":"PA James","year":"2006","unstructured":"James PA, Doherty R, Harris M et al (2006) Optimal selection of individuals for BRCA mutation testing: a comparison of available methods. J Clin Oncol 24(4):707\u2013715","journal-title":"J Clin Oncol"},{"key":"9362_CR78","doi-asserted-by":"crossref","first-page":"R28","DOI":"10.1186\/bcr2576","volume":"12","author":"N Mavaddat","year":"2010","unstructured":"Mavaddat N, Rebbeck TR, Lakhani SR, Easton DF, Antonis AC (2010) Incorporating tumour pathology information into breast cancer risk prediction algorithms. Breast Cancer Res 12: R28","journal-title":"Breast Cancer Res"},{"issue":"1","key":"9362_CR79","doi-asserted-by":"crossref","first-page":"R8","DOI":"10.1186\/bcr2223","volume":"11","author":"EB Gomez Garcia","year":"2009","unstructured":"Gomez Garcia EB, Oosterwijk JC, Timmermans M et al (2009) A method to assess the clinical significance of unclassified variants in the BRCA1 and BRCA2 genes based on cancer family history. Breast Cancer Res 11(1):R8","journal-title":"Breast Cancer Res"},{"issue":"11","key":"9362_CR80","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1001\/jama.1997.03540350065035","volume":"277","author":"W Burke","year":"1997","unstructured":"Burke W, Petersen G, Lynch P et al (1997) Recommendations for follow-up care of individuals with an inherited predisposition to cancer. I. Hereditary nonpolyposis colon cancer. Cancer genetics studies consortium. JAMA 277(11):915\u2013919","journal-title":"JAMA"},{"issue":"5","key":"9362_CR81","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1093\/annonc\/mdn724","volume":"20","author":"M Pensabene","year":"2009","unstructured":"Pensabene M, Spagnoletti I, Capuano I et al (2009) Two mutations of BRCA2 gene at exon and splicing site in a woman who underwent oncogenetic counseling. Ann Oncol 20(5):874\u2013878","journal-title":"Ann Oncol"},{"issue":"4","key":"9362_CR82","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1086\/424388","volume":"75","author":"DE Goldgar","year":"2004","unstructured":"Goldgar DE, Easton DF, Deffenbaugh AM, Monteiro AN, Tavtigian SV, Couch FJ (2004) Integrated evaluation of DNA sequence variants of unknown clinical significance: application to BRCA1 and BRCA2. Am J Hum Genet 75(4):535\u2013544","journal-title":"Am J Hum Genet"},{"issue":"4","key":"9362_CR83","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1158\/0008-5472.CAN-05-3546","volume":"66","author":"G Chenevix-Trench","year":"2006","unstructured":"Chenevix-Trench G, Healey S, Lakhani S et al (2006) Genetic and histopathologic evaluation of BRCA1 and BRCA2 DNA sequence variants of unknown clinical significance. Cancer Res 66(4):2019\u20132027","journal-title":"Cancer Res"},{"issue":"5","key":"9362_CR84","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/humu.20470","volume":"28","author":"A Osorio","year":"2007","unstructured":"Osorio A, Milne RL, Honrado E et al (2007) Classification of missense variants of unknown significance in BRCA1 based on clinical and tumor information. Hum Mutat 28(5):477\u2013485","journal-title":"Hum Mutat"},{"issue":"1\u20132","key":"9362_CR85","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.mrfmmm.2008.07.005","volume":"644","author":"S Tommasi","year":"2008","unstructured":"Tommasi S, Pilato B, Pinto R et al (2008) Molecular and in silico analysis of BRCA1 and BRCA2 variants. Mutat Res 644(1\u20132):64\u201370","journal-title":"Mutat Res"},{"issue":"33","key":"9362_CR86","doi-asserted-by":"crossref","first-page":"5393","DOI":"10.1200\/JCO.2008.17.8228","volume":"26","author":"AD Spearman","year":"2008","unstructured":"Spearman AD, Sweet K, Zhou XP, McLennan J, Couch FJ, Toland AE (2008) Clinically applicable models to characterize BRCA1 and BRCA2 variants of uncertain significance. J Clin Oncol 26(33):5393\u20135400","journal-title":"J Clin Oncol"},{"issue":"1","key":"9362_CR87","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1136\/jmg.2005.033258","volume":"43","author":"PK Lovelock","year":"2006","unstructured":"Lovelock PK, Healey S, Au W et al (2006) Genetic, functional, and histopathological evaluation of two C-terminal BRCA1 missense variants. J Med Genet 43(1):74\u201383","journal-title":"J Med Genet"},{"issue":"9064","key":"9362_CR88","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/S0140-6736(96)10109-4","volume":"349","author":"BCL Consortium","year":"1997","unstructured":"Consortium BCL (1997) Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Lancet 349(9064):1505\u20131510","journal-title":"Lancet"},{"issue":"1","key":"9362_CR89","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cncr.11048","volume":"97","author":"C Adem","year":"2003","unstructured":"Adem C, Reynolds C, Soderberg CL et al (2003) Pathologic characteristics of breast parenchyma in patients with hereditary breast carcinoma, including BRCA1 and BRCA2 mutation carriers. Cancer 97(1):1\u201311","journal-title":"Cancer"},{"issue":"6","key":"9362_CR90","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1200\/JCO.2005.04.0345","volume":"25","author":"ES Hwang","year":"2007","unstructured":"Hwang ES, McLennan JL, Moore DH, Crawford BB, Esserman LJ, Ziegler JL (2007) Ductal carcinoma in situ in BRCA mutation carriers. J Clin Oncol 25(6):642\u2013647","journal-title":"J Clin Oncol"}],"container-title":["Familial Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-010-9362-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10689-010-9362-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-010-9362-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T21:46:03Z","timestamp":1559252763000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10689-010-9362-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,25]]},"references-count":90,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["9362"],"URL":"https:\/\/doi.org\/10.1007\/s10689-010-9362-5","relation":{},"ISSN":["1389-9600","1573-7292"],"issn-type":[{"value":"1389-9600","type":"print"},{"value":"1573-7292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6,25]]}}}